Lathers C M, Charles J B
NASA/Johnson Space Center, Space Biomedical Research Institute, Houston, Texas.
J Clin Pharmacol. 1994 May;34(5):403-17. doi: 10.1002/j.1552-4604.1994.tb04980.x.
Orthostatic hypotension after even short space flights has affected a significant number of astronauts. Given the need for astronauts to function at a high level of efficiency during and after their return from space, the application of pharmacologic and other treatments is strongly indicated. This report addresses the clinical problem of orthostatic hypotension and its treatments to ascertain whether pharmacologic or physiologic treatment may be useful in the prevention of orthostatic hypotension associated with space flight. Treatment of orthostatic hypotension in patients now includes increasing intravascular volume with high sodium intake and mineralocorticoids, or increasing vascular resistance through the use of drugs to stimulate alpha or block beta vascular receptors. Earlier treatment used oral sympathomimetic ephedrine hydrochloride alone or with "head-up" bed rest. Then long-acting adrenocortical steroid desoxycorticosterone preparations with high-salt diets were used to expand volume. Fludrocortisone was shown to prevent the orthostatic drop in blood pressure. The combination of the sympathomimetic amine hydroxyamphetamine and a monoamine oxidase inhibitor tranylcypromine has been used, as has indomethacin alone. Davies et al. used mineralocorticoids at low doses concomitantly with alpha-agonists to increase vasoconstrictor action. Schirger et al used tranylcypromine and methylphenidate with or without a Jobst elastic leotard garment or the alpha-adrenergic agonist midodrine (which stimulates both arterial and venous systems without direct central nervous system or cardiac effects). Vernikos et al established that the combination of fludrocortisone, dextroamphetamine, and atropine exhibited a beneficial effect on orthostatic hypotension induced by 7-day 6 degrees head-down bed rest (a model used to simulate the weightlessness of space flight). Thus, there are numerous drugs that, in combination with mechanical techniques, including lower body negative pressure to elevate transmural pressure, could be studied to treat orthostatic hypotension after space flight.
即使是短时间的太空飞行后,体位性低血压也影响了相当数量的宇航员。鉴于宇航员在太空飞行期间及返回后需要高效运作,强烈建议应用药物及其他治疗方法。本报告探讨体位性低血压的临床问题及其治疗方法,以确定药物治疗或生理治疗是否有助于预防与太空飞行相关的体位性低血压。目前,患者体位性低血压的治疗方法包括通过高钠摄入和使用盐皮质激素增加血管内容量,或通过使用药物刺激α血管受体或阻断β血管受体来增加血管阻力。早期治疗仅使用口服拟交感神经药盐酸麻黄碱,或联合“头高位”卧床休息。随后使用长效肾上腺皮质类固醇脱氧皮质酮制剂并搭配高盐饮食来扩充容量。已证明氟氢可的松可预防血压的体位性下降。曾使用拟交感神经胺羟苯丙胺与单胺氧化酶抑制剂反苯环丙胺的组合,也单独使用过吲哚美辛。戴维斯等人使用低剂量盐皮质激素并联合α激动剂以增强血管收缩作用。施尔格等人使用反苯环丙胺和哌醋甲酯,同时或不使用乔布斯特弹性紧身衣或α肾上腺素能激动剂米多君(其刺激动脉和静脉系统,无直接中枢神经系统或心脏效应)。韦尔尼科斯等人证实,氟氢可的松、右旋苯丙胺和阿托品的组合对7天6°头低位卧床休息诱导的体位性低血压(一种用于模拟太空飞行失重状态的模型)具有有益效果。因此,有许多药物可与包括下体负压以提高跨壁压力在内的机械技术联合使用,用于研究治疗太空飞行后的体位性低血压。